BioSpace News Archive

Policy

Government of Canada Supports Research on COVID-19 Treatments for Transplant Recipients

The Government of Canada recognizes the lifesaving impact that organ donation has on those in need of a transplantation.

June 9, 2023
·
3 min read
FDA

USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States

PharmAla Biotech Holdings Inc., a biotechnology company focused on the research, development, and manufacturing of MDXX class molecules, is pleased to report that the US Food and Drug Administration has approved a clinical trial utilizing PharmAla’s LaNeo MDMA Investigational Medical Product capsules.

June 9, 2023
·
4 min read
Pharm Country

Ocugen, Inc. Announces Adjournment of Annual Meeting of Shareholders

Ocugen, Inc. announced that the Company’s 2023 Annual Meeting of Shareholders was convened and adjourned, without any business being conducted, due to lack of the required quorum.

June 9, 2023
·
4 min read
Pharm Country

Cellectis Presents Updated Clinical and Translational Data on BALLI-01 at the European Hematology Association (EHA) 2023

Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS) presented today updated clinical and translational data on its clinical trial BALLI-01 (evaluating UCART22) at the European Hematology Association (EHA) 2023.

June 9, 2023
·
6 min read
Bio NC

Labcorp Announces Information in Connection with its Spin-off of Fortrea

Labcorp, a leading global life sciences company, announced the following record and distribution dates for the spin-off of Fortrea Holdings Inc., a wholly owned subsidiary of Labcorp.

June 9, 2023
·
3 min read